Acorda Therapeutics reported $4.06M in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US USD 182.55M 20.97M
Acorda Therapeutics ACOR:US USD 4.06M 34.44M
Agios Pharmaceuticals AGIO:US USD -24371000 114.53M
Amgen AMGN:US USD 4.61B 695M
Anika Therapeutics ANIK:US USD 46.29M 227K
Aptinyx Inc APTX:US USD 14.66M 2.45M
Arrowhead Research ARWR:US USD 104.68M 10.72M
Biogen BIIB:US USD 1.84B 650.7M
Biomarin Pharmaceutical BMRN:US USD 562.04M 54.28M
Cara Therapeutics CARA:US USD 34.57M 90K
Clovis Oncology CLVS:US USD 74.9M 16.63M
Cytokinetics CYTK:US USD 128.99M 4.22M
Enanta Pharmaceuticals ENTA:US USD 53.6M 6.23M
Gilead Sciences GILD:US USD 5.12B 917M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Halozyme Therapeutics HALO:US USD 106.99M 21.41M
Heron Therapeutics HRTX:US USD 50.38M 18.06M
Insmed INSM:US USD 210.77M 15.35M
Ligand Pharmaceuticals LGND:US USD 70.48M 5.93M
Mannkind MNKD:US USD 48.85M 6.41M
Merck MRK:GR EUR 4.77B 199M
Moderna Inc MRNA:US USD 3.5B 1.31B
Neurocrine Biosciences NBIX:US USD 308.6M 8.5M
Novartis NOVN:VX USD 11.05B 378M
Pfizer PFE:US USD 19.12B 5.9B
Teva Pharmaceutical TEVA:IT USD 4.74B 1.56B
Ultragenyx Pharmaceutical RARE:US USD 248.98M 66.79M
Vertex Pharmaceuticals VRTX:US USD 1.27B 61.6M